XBiotech Inc. - Common Stock — Cash Flow (NASDAQ:XBIT)

Financials

Cash from operating activities -65.15 M69.44 M-14.82 M-18.73 M-30.96 M-39.92 M -42.17 M Cash from investing activities -3.73 M-3.52 M-63.89 M61.5 M-1.3 M-289 K -186 K Cash from financing activities -409.72 M-67.01 M0-9 00010.45 M-10.25 M 0 Free cash flow -65.15 M69.44 M-14.82 M-18.73 M-30.96 M-40.21 M -42.36 M

XBiotech Inc. - Common Stock

XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases.

XBIT

Financials

XBiotech Inc. - Common Stock

News

XBiotech shareholders approve board nominees and key proposals at annual meeting

XBiotech appoints Thomas Kündig and Craig Rademaker to board of directors